» Articles » PMID: 34994210

D-dimer Kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases

Overview
Publisher Sage Publications
Date 2022 Jan 7
PMID 34994210
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Although D-dimer is a useful biomarker of thrombosis, there are many D-dimer kits, with high and low fibrinogen and fibrin degradation products (FDP)/ D-dimer ratios.

Methods: Plasma D-dimer levels were measured using three different kits in critically ill patients to examine the usefulness of such measurements for detecting the thrombotic diseases and determining the correlation with the FDP and FDP/D-dimer ratio.

Results: Although three D-dimer kits showed marked utility for diagnosing disseminated intravascular coagulation (DIC) and peripheral arterial and venous thromboembolism (PAVTE), the D-dimer levels determined using the three kits varied among diseases. Indeed, one D-dimer kit showed a high FDP/D-dimer ratio, and another kit showed a low FDP/D-dimer ratio. D-dimer kit with low FDP/D-dimer ratio tended to have high cut-off values and low specificity for diagnosing DIC and PAVTE. In D-dimer kit with high FDP/D-dimer ratio, FDP/D-dimer ratios in patients with thrombosis was significantly higher than that in patients without thrombosis.

Conclusion: All three D-dimer kits show utility for detecting thrombotic diseases. However, the D-dimer levels determined using the kits varied due to differences in the FDP/D-dimer ratio. In combination with the FDP level, a D-dimer kit with a high FDP/D-dimer ratio may be useful.

Citing Articles

Retinal Vessel Analysis and Microvascular Abnormalities in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms.

Roszkowska A, Leanza R, Aragona E, Gargiulo L, Alibrandi A, Arrigo A J Clin Med. 2024; 13(8).

PMID: 38673505 PMC: 11051207. DOI: 10.3390/jcm13082232.


Reference Value Fibrin Monomer in Healthy Children: A Cross-Sectional Study.

Tuan T, Xoay T, My T, Duyen N, Thi Trang N, Kien N Clin Appl Thromb Hemost. 2024; 30:10760296241247560.

PMID: 38656143 PMC: 11044795. DOI: 10.1177/10760296241247560.


COVID severity test (CoST sensor)-An electrochemical immunosensing approach to stratify disease severity.

Madhurantakam S, Karnam J, Muthukumar S, Prasad S Bioeng Transl Med. 2023; 8(5):e10566.

PMID: 37693054 PMC: 10486328. DOI: 10.1002/btm2.10566.


Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review.

Gupta S, Sandhu H, Nadar K, Ocampo Escobedo R, Gupta R, Subbappa A J Int Soc Prev Community Dent. 2023; 13(2):89-95.

PMID: 37223447 PMC: 10202252. DOI: 10.4103/jispcd.JISPCD_229_22.


Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases.

Ezaki M, Wada H, Ichikawa Y, Ikeda N, Shiraki K, Yamamoto A J Clin Med. 2023; 12(7).

PMID: 37048680 PMC: 10095172. DOI: 10.3390/jcm12072597.


References
1.
Hasegawa M, Wada H, Miyazaki S, Yamaguchi T, Wakabayashi H, Fujimoto N . The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery. Clin Appl Thromb Hemost. 2017; 24(1):107-114. PMC: 6714636. DOI: 10.1177/1076029616674824. View

2.
Kawasugi K, Wada H, Honda G, Kawano N, Uchiyama T, Madoiwa S . Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa. Thromb J. 2021; 19(1):12. PMC: 7908729. DOI: 10.1186/s12959-021-00264-z. View

3.
Hasegawa M, Wada H, Wakabayashi H, Yoshida K, Miyamoto N, Asanuma K . The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery. Clin Chim Acta. 2013; 425:109-13. DOI: 10.1016/j.cca.2013.07.009. View

4.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

5.
Righini M, van Es J, den Exter P, Roy P, Verschuren F, Ghuysen A . Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014; 311(11):1117-24. DOI: 10.1001/jama.2014.2135. View